CLOVER HEALTH INVESTMENTS, CORP. /DE·4

Mar 18, 6:11 PM ET

Reynoso Jamie L. 4

Research Summary

AI-generated summary

Updated

Clover Health (CLOV) CEO Jamie Reynoso Sells Shares

What Happened
Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments, sold 5,833 shares in open‑market transactions on March 18, 2026. The weighted average sale price was $1.91 per share for total proceeds of $11,141. This was a sale (not a purchase or option exercise).

Key Details

  • Transaction date: 2026-03-18; Transaction type: Sale (Code S), open market/private sale.
  • Price: Weighted average $1.91; individual trades ranged from $1.87 to $1.96 (per footnote).
  • Total proceeds: $11,141.
  • Shares owned after the transaction: Not specified in the supplied filing summary.
  • Footnote: Sale was effected pursuant to a Rule 10b5‑1 trading plan adopted March 13, 2025. The filer can provide a breakdown of shares sold at each price on request.
  • Filing/timeliness: Reported on Form 4 with a filing date of March 18, 2026 (no late‑filing indication in the provided data).

Context
A 10b5‑1 plan indicates these trades were pre‑arranged and scheduled, which is a common mechanism for insiders to sell holdings while reducing the risk of trading on material nonpublic information. Sales under such plans are typically routine and not a definitive signal about future company performance.